Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Pallor
ADR ID BADD_A03258
ADR Hierarchy
24      Vascular disorders
24.03      Vascular disorders NEC
24.03.04      Site specific vascular disorders NEC
24.03.04.001      Pallor
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.03      General signs and symptoms NEC
08.01.03.032      Pallor
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.03      Dermal and epidermal conditions NEC
23.03.03.031      Pallor
Description A clinical manifestation consisting of an unnatural paleness of the skin. [MeSH]
MedDRA Code 10033546
MeSH ID D010167
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Blanching of skin | Complexion ill | Looked pale | Pale | Pale skin | Pallor | Pallor facial | Pallor generalized | Pallor of skin | Pale lips | Pale nail beds | Blanching | Pallors
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01378Memantine--
BADD_D01381Mepact--
BADD_D01384Meperidine--
BADD_D01387Mepivacaine0.000179%
BADD_D01391Mercaptoethanesulfonic acid--
BADD_D01392Mercaptopurine--
BADD_D01398Mesna--
BADD_D01428Methylergonovine0.003365%
BADD_D01431Methylphenidate0.000275%
BADD_D01433Methylprednisolone0.000342%
BADD_D01445Metoprolol0.000033%
BADD_D01449Metronidazole--
BADD_D01465Miglustat0.004312%
BADD_D01477Misoprostol--
BADD_D01496Montelukast0.000073%
BADD_D01498Morphine--
BADD_D01507Mycophenolate mofetil--
BADD_D01508Mycophenolic acid--
BADD_D01533Naproxen0.000019%
BADD_D01546Nefazodone--
BADD_D01547Nefazodone hydrochloride--
BADD_D01564Nicotine--
BADD_D01566Nifedipine0.000187%
BADD_D01571Nitazoxanide0.000553%
BADD_D01576Nitrofurantoin--
BADD_D01579Nitroglycerin--
BADD_D01583Norepinephrine--
BADD_D01584Norepinephrine bitartrate--
BADD_D01598Ofloxacin0.000167%
BADD_D01599Olanzapine--
The 7th Page    First    Pre   7 8 9 10 11    Next   Last    Total 11 Pages